3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monogenetic Disorders Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7D1925
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Monogenetic Disorders Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Monogenetic Disorders Testing Market Research Report 2025

Code: QYRE-Auto-7D1925
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Monogenetic Disorders Testing Market

The global market for Monogenetic Disorders Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to Mendel"s Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher"s disease, Huntington"s disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
This report aims to provide a comprehensive presentation of the global market for Monogenetic Disorders Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monogenetic Disorders Testing.
The Monogenetic Disorders Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monogenetic Disorders Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monogenetic Disorders Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Monogenetic Disorders Testing Market Report

Report Metric Details
Report Name Monogenetic Disorders Testing Market
Segment by Type
  • Carrier Testing
  • Diagnostic Testing
  • New-Born Screening
  • Predictive & Pre-Symptomatic Testing
  • Prenatal Testing
  • Others
Segment by Application
  • Hospitals
  • Specialized Clinics
  • Ambulatory Surgical Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, PerkinElmer, Roche, Bio-Rad, Transgenomic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Monogenetic Disorders Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Monogenetic Disorders Testing Market report?

Ans: The main players in the Monogenetic Disorders Testing Market are Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, PerkinElmer, Roche, Bio-Rad, Transgenomic

What are the Application segmentation covered in the Monogenetic Disorders Testing Market report?

Ans: The Applications covered in the Monogenetic Disorders Testing Market report are Hospitals, Specialized Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Monogenetic Disorders Testing Market report?

Ans: The Types covered in the Monogenetic Disorders Testing Market report are Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive & Pre-Symptomatic Testing, Prenatal Testing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monogenetic Disorders Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive & Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Monogenetic Disorders Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monogenetic Disorders Testing Market Perspective (2020-2031)
2.2 Global Monogenetic Disorders Testing Growth Trends by Region
2.2.1 Global Monogenetic Disorders Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monogenetic Disorders Testing Historic Market Size by Region (2020-2025)
2.2.3 Monogenetic Disorders Testing Forecasted Market Size by Region (2026-2031)
2.3 Monogenetic Disorders Testing Market Dynamics
2.3.1 Monogenetic Disorders Testing Industry Trends
2.3.2 Monogenetic Disorders Testing Market Drivers
2.3.3 Monogenetic Disorders Testing Market Challenges
2.3.4 Monogenetic Disorders Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monogenetic Disorders Testing Players by Revenue
3.1.1 Global Top Monogenetic Disorders Testing Players by Revenue (2020-2025)
3.1.2 Global Monogenetic Disorders Testing Revenue Market Share by Players (2020-2025)
3.2 Global Monogenetic Disorders Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monogenetic Disorders Testing Revenue
3.4 Global Monogenetic Disorders Testing Market Concentration Ratio
3.4.1 Global Monogenetic Disorders Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monogenetic Disorders Testing Revenue in 2024
3.5 Global Key Players of Monogenetic Disorders Testing Head office and Area Served
3.6 Global Key Players of Monogenetic Disorders Testing, Product and Application
3.7 Global Key Players of Monogenetic Disorders Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monogenetic Disorders Testing Breakdown Data by Type
4.1 Global Monogenetic Disorders Testing Historic Market Size by Type (2020-2025)
4.2 Global Monogenetic Disorders Testing Forecasted Market Size by Type (2026-2031)
5 Monogenetic Disorders Testing Breakdown Data by Application
5.1 Global Monogenetic Disorders Testing Historic Market Size by Application (2020-2025)
5.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monogenetic Disorders Testing Market Size (2020-2031)
6.2 North America Monogenetic Disorders Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monogenetic Disorders Testing Market Size by Country (2020-2025)
6.4 North America Monogenetic Disorders Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monogenetic Disorders Testing Market Size (2020-2031)
7.2 Europe Monogenetic Disorders Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monogenetic Disorders Testing Market Size by Country (2020-2025)
7.4 Europe Monogenetic Disorders Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monogenetic Disorders Testing Market Size (2020-2031)
8.2 Asia-Pacific Monogenetic Disorders Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monogenetic Disorders Testing Market Size (2020-2031)
9.2 Latin America Monogenetic Disorders Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monogenetic Disorders Testing Market Size by Country (2020-2025)
9.4 Latin America Monogenetic Disorders Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monogenetic Disorders Testing Market Size (2020-2031)
10.2 Middle East & Africa Monogenetic Disorders Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celera Group
11.1.1 Celera Group Company Details
11.1.2 Celera Group Business Overview
11.1.3 Celera Group Monogenetic Disorders Testing Introduction
11.1.4 Celera Group Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.1.5 Celera Group Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Monogenetic Disorders Testing Introduction
11.2.4 Abbott Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 ELITech Group
11.4.1 ELITech Group Company Details
11.4.2 ELITech Group Business Overview
11.4.3 ELITech Group Monogenetic Disorders Testing Introduction
11.4.4 ELITech Group Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.4.5 ELITech Group Recent Development
11.5 Quest
11.5.1 Quest Company Details
11.5.2 Quest Business Overview
11.5.3 Quest Monogenetic Disorders Testing Introduction
11.5.4 Quest Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.5.5 Quest Recent Development
11.6 AutoGenomics
11.6.1 AutoGenomics Company Details
11.6.2 AutoGenomics Business Overview
11.6.3 AutoGenomics Monogenetic Disorders Testing Introduction
11.6.4 AutoGenomics Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.6.5 AutoGenomics Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Details
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Monogenetic Disorders Testing Introduction
11.7.4 PerkinElmer Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.7.5 PerkinElmer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Monogenetic Disorders Testing Introduction
11.8.4 Roche Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.8.5 Roche Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Monogenetic Disorders Testing Introduction
11.9.4 Bio-Rad Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.9.5 Bio-Rad Recent Development
11.10 Transgenomic
11.10.1 Transgenomic Company Details
11.10.2 Transgenomic Business Overview
11.10.3 Transgenomic Monogenetic Disorders Testing Introduction
11.10.4 Transgenomic Revenue in Monogenetic Disorders Testing Business (2020-2025)
11.10.5 Transgenomic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Monogenetic Disorders Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Carrier Testing
 Table 3. Key Players of Diagnostic Testing
 Table 4. Key Players of New-Born Screening
 Table 5. Key Players of Predictive & Pre-Symptomatic Testing
 Table 6. Key Players of Prenatal Testing
 Table 7. Key Players of Others
 Table 8. Global Monogenetic Disorders Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Monogenetic Disorders Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Monogenetic Disorders Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Monogenetic Disorders Testing Market Share by Region (2020-2025)
 Table 12. Global Monogenetic Disorders Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Monogenetic Disorders Testing Market Share by Region (2026-2031)
 Table 14. Monogenetic Disorders Testing Market Trends
 Table 15. Monogenetic Disorders Testing Market Drivers
 Table 16. Monogenetic Disorders Testing Market Challenges
 Table 17. Monogenetic Disorders Testing Market Restraints
 Table 18. Global Monogenetic Disorders Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Monogenetic Disorders Testing Market Share by Players (2020-2025)
 Table 20. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2024)
 Table 21. Ranking of Global Top Monogenetic Disorders Testing Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Monogenetic Disorders Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Monogenetic Disorders Testing, Headquarters and Area Served
 Table 24. Global Key Players of Monogenetic Disorders Testing, Product and Application
 Table 25. Global Key Players of Monogenetic Disorders Testing, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Monogenetic Disorders Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Monogenetic Disorders Testing Revenue Market Share by Type (2020-2025)
 Table 29. Global Monogenetic Disorders Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Monogenetic Disorders Testing Revenue Market Share by Type (2026-2031)
 Table 31. Global Monogenetic Disorders Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Monogenetic Disorders Testing Revenue Market Share by Application (2020-2025)
 Table 33. Global Monogenetic Disorders Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Monogenetic Disorders Testing Revenue Market Share by Application (2026-2031)
 Table 35. North America Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Monogenetic Disorders Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Monogenetic Disorders Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Monogenetic Disorders Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Monogenetic Disorders Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Monogenetic Disorders Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Monogenetic Disorders Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Monogenetic Disorders Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Celera Group Company Details
 Table 51. Celera Group Business Overview
 Table 52. Celera Group Monogenetic Disorders Testing Product
 Table 53. Celera Group Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 54. Celera Group Recent Development
 Table 55. Abbott Company Details
 Table 56. Abbott Business Overview
 Table 57. Abbott Monogenetic Disorders Testing Product
 Table 58. Abbott Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 59. Abbott Recent Development
 Table 60. Thermo Fisher Scientific Company Details
 Table 61. Thermo Fisher Scientific Business Overview
 Table 62. Thermo Fisher Scientific Monogenetic Disorders Testing Product
 Table 63. Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 64. Thermo Fisher Scientific Recent Development
 Table 65. ELITech Group Company Details
 Table 66. ELITech Group Business Overview
 Table 67. ELITech Group Monogenetic Disorders Testing Product
 Table 68. ELITech Group Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 69. ELITech Group Recent Development
 Table 70. Quest Company Details
 Table 71. Quest Business Overview
 Table 72. Quest Monogenetic Disorders Testing Product
 Table 73. Quest Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 74. Quest Recent Development
 Table 75. AutoGenomics Company Details
 Table 76. AutoGenomics Business Overview
 Table 77. AutoGenomics Monogenetic Disorders Testing Product
 Table 78. AutoGenomics Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 79. AutoGenomics Recent Development
 Table 80. PerkinElmer Company Details
 Table 81. PerkinElmer Business Overview
 Table 82. PerkinElmer Monogenetic Disorders Testing Product
 Table 83. PerkinElmer Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 84. PerkinElmer Recent Development
 Table 85. Roche Company Details
 Table 86. Roche Business Overview
 Table 87. Roche Monogenetic Disorders Testing Product
 Table 88. Roche Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 89. Roche Recent Development
 Table 90. Bio-Rad Company Details
 Table 91. Bio-Rad Business Overview
 Table 92. Bio-Rad Monogenetic Disorders Testing Product
 Table 93. Bio-Rad Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 94. Bio-Rad Recent Development
 Table 95. Transgenomic Company Details
 Table 96. Transgenomic Business Overview
 Table 97. Transgenomic Monogenetic Disorders Testing Product
 Table 98. Transgenomic Revenue in Monogenetic Disorders Testing Business (2020-2025) & (US$ Million)
 Table 99. Transgenomic Recent Development
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Authors List of This Report


List of Figures
 Figure 1. Monogenetic Disorders Testing Picture
 Figure 2. Global Monogenetic Disorders Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Monogenetic Disorders Testing Market Share by Type: 2024 VS 2031
 Figure 4. Carrier Testing Features
 Figure 5. Diagnostic Testing Features
 Figure 6. New-Born Screening Features
 Figure 7. Predictive & Pre-Symptomatic Testing Features
 Figure 8. Prenatal Testing Features
 Figure 9. Others Features
 Figure 10. Global Monogenetic Disorders Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Monogenetic Disorders Testing Market Share by Application: 2024 VS 2031
 Figure 12. Hospitals Case Studies
 Figure 13. Specialized Clinics Case Studies
 Figure 14. Ambulatory Surgical Centers Case Studies
 Figure 15. Monogenetic Disorders Testing Report Years Considered
 Figure 16. Global Monogenetic Disorders Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Monogenetic Disorders Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Monogenetic Disorders Testing Market Share by Region: 2024 VS 2031
 Figure 19. Global Monogenetic Disorders Testing Market Share by Players in 2024
 Figure 20. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Monogenetic Disorders Testing Revenue in 2024
 Figure 22. North America Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Monogenetic Disorders Testing Market Share by Country (2020-2031)
 Figure 24. United States Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Monogenetic Disorders Testing Market Share by Country (2020-2031)
 Figure 28. Germany Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Monogenetic Disorders Testing Market Share by Region (2020-2031)
 Figure 36. China Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Monogenetic Disorders Testing Market Share by Country (2020-2031)
 Figure 44. Mexico Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Monogenetic Disorders Testing Market Share by Country (2020-2031)
 Figure 48. Turkey Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Monogenetic Disorders Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Celera Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 52. Abbott Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 54. ELITech Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 55. Quest Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 56. AutoGenomics Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 57. PerkinElmer Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 58. Roche Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 59. Bio-Rad Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 60. Transgenomic Revenue Growth Rate in Monogenetic Disorders Testing Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI